We are live on ! Find out more
MCRB icon

Seres Therapeutics
MCRB

60 hedge funds and large institutions have $409M invested in Seres Therapeutics in 2015 Q3 according to their latest regulatory filings, with 31 funds opening new positions, 14 increasing their positions, 7 reducing their positions, and 16 closing their positions.

New
Increased
Maintained
Reduced
Closed

158,200% more call options, than puts

Call options by funds: $1.58M | Put options by funds: $1K

100% more repeat investments, than reductions

Existing positions increased: 14 | Existing positions reduced: 7

94% more first-time investments, than exits

New positions opened: 31 | Existing positions closed: 16

33% more funds holding

Funds holding: 45 → 60 (+15)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

13% less capital invested

Capital invested by funds: $471M → $409M (-$62.2M)

Holders
60
Holders Change
+15
Holders Change %
+33.33%
% of All Funds
1.68%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
31
Increased
14
Reduced
7
Closed
16
Calls
$1.58M
Puts
$1K
Net Calls
+$1.58M
Net Calls Change
+$1.58M

Top Buyers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
+$24.7M
2
Federated Hermes
Federated Hermes
Pennsylvania
+$23.3M
3
Vanguard Group
Vanguard Group
Pennsylvania
+$18.8M
4
BFA
BlackRock Fund Advisors
California
+$8.35M
5
BM
Bridger Management
New York
+$8.22M

Top Sellers

Rank Fund Capital Flow
1
BA
BlackRock Advisors
Delaware
-$12.6M
2
Citadel Advisors
Citadel Advisors
Florida
-$8.02M
3
Capital World Investors
Capital World Investors
California
-$3.57M
4
JHIU
Janus Henderson Investors US
Colorado
-$2.58M
5
PA
Perceptive Advisors
New York
-$2.08M
Name Holding Trade Value Shares
Change 		Change in
Stake
UBS AM
26
UBS AM
Illinois
$2.83M +$1.11M +1,362 +40%
State Street
27
State Street
Massachusetts
$2.77M +$3.81M +4,676 New
JP Morgan Chase
28
JP Morgan Chase
New York
$2.03M +$1.78M +2,185 +176%
Geode Capital Management
29
Geode Capital Management
Massachusetts
$1.97M +$2.72M +3,329 New
SM
30
Sabby Management
Florida
$1.92M +$2.64M +3,239 New
BlackRock
31
BlackRock
New York
$1.63M – – –
BIM
32
BlackRock Investment Management
Delaware
$1.44M +$1.15M +1,412 +139%
CS
33
Credit Suisse
Switzerland
$865K +$1.19M +1,459 New
Northern Trust
34
Northern Trust
Illinois
$852K +$1.17M +1,437 New
Alyeska Investment Group
35
Alyeska Investment Group
Illinois
$769K -$165K -202 -13%
TCIM
36
TIAA CREF Investment Management
New York
$755K +$1.04M +1,273 New
Bank of New York Mellon
37
Bank of New York Mellon
New York
$597K +$821K +1,006 New
Charles Schwab
38
Charles Schwab
California
$463K +$637K +781 New
California State Teachers Retirement System (CalSTRS)
39
California State Teachers Retirement System (CalSTRS)
California
$462K +$636K +780 New
TD Asset Management
40
TD Asset Management
Ontario, Canada
$451K +$24.5K +30 +4%
Goldman Sachs
41
Goldman Sachs
New York
$357K +$490K +601 New
Renaissance Technologies
42
Renaissance Technologies
New York
$323K +$445K +545 New
Morgan Stanley
43
Morgan Stanley
New York
$307K +$321K +394 +315%
TA
44
Teachers Advisors
New York
$257K +$353K +433 New
Susquehanna International Group
45
Susquehanna International Group
Pennsylvania
$210K +$290K +355 New
Citigroup
46
Citigroup
New York
$110K +$152K +186 New
Bank of America
47
Bank of America
North Carolina
$105K +$145K +178 New
SO
48
STRS Ohio
Ohio
$82K +$114K +140 New
Deutsche Bank
49
Deutsche Bank
Germany
$70K -$697K -854 -88%
NFA
50
Nationwide Fund Advisors
Ohio
$58K +$79.9K +98 New
1
2
3 4

MCRB Hedge Fund Activity: Q3 2015 in Review

60 of the 3,582 institutional investors tracked by Wall St. Rank reported a position in Seres Therapeutics (MCRB) for Q3 2015, worth a combined $409M — down 13% from $471M a quarter earlier.

Buyers outnumbered sellers: 31 funds opened new MCRB positions and 16 closed out — a net gain of 15 holders — while 14 added to existing stakes and 7 trimmed.

The largest buyer was Fidelity Investments, adding an estimated $24.7M. The largest seller was BlackRock Advisors, cutting an estimated $12.6M.

  • 60 institutional investors held Seres Therapeutics (MCRB) as of Q3 2015, up from 45 in Q2 2015.
  • Funds reported $409M of Seres Therapeutics stock for Q3 2015, down 13% quarter-over-quarter.
  • 31 funds opened new Seres Therapeutics positions in Q3 2015 and 16 closed out, a net change of +15 holders.
  • The largest Seres Therapeutics buyer in Q3 2015 was Fidelity Investments, an estimated $24.7M added.
  • The largest Seres Therapeutics seller in Q3 2015 was BlackRock Advisors, an estimated $12.6M sold.

Based on aggregated 13F filings for Q3 2015.